Catalyst Pharmaceuticals (CPRX) Deferred Taxes (2020 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Deferred Taxes of $2.3 million for Q1 2026, down 48.22% on a QoQ basis from $4.5 million in Q4 2025, and up 0.65% year-over-year from $2.3 million in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Deferred Taxes (2020 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Deferred Taxes history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- Quarterly Deferred Taxes rose 0.65% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (down 31.11% YoY) and the FY2025 annual result came in at $6.8 million, down 27.05% from the prior year.
- Deferred Taxes was $2.3 million for Q1 2026 at Catalyst Pharmaceuticals, down from $4.5 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $13.9 million in Q3 2023 and bottomed at -$2.6 million in Q4 2024.
- A 5-year average of $1.9 million and a median of $1.6 million in 2024 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2023 — Deferred Taxes soared 1592.83% — and 2024, when it plunged 189.35%.
- Catalyst Pharmaceuticals' Deferred Taxes stood at -$1.3 million in 2022, then jumped by 31.28% to -$883000.0 in 2023, then plunged by 189.35% to -$2.6 million in 2024, then soared by 276.56% to $4.5 million in 2025, then plunged by 48.22% to $2.3 million in 2026.
- Business Quant data shows CPRX's Deferred Taxes at $2.3 million in Q1 2026, $4.5 million in Q4 2025, and -$2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | 4.51 Mn |
| Sep 30, 2025 | -2.42 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | -2.56 Mn |
| Sep 30, 2024 | 8.58 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | -883,000.00 |
| Sep 30, 2023 | 13.94 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -934,000.00 |
| Jun 30, 2022 | -817,000.00 |
| Mar 31, 2022 | -1.90 Mn |
| Dec 31, 2021 | -2.75 Mn |
| Sep 30, 2021 | -2.30 Mn |
| Jun 30, 2021 | -2.72 Mn |